BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18325574)

  • 21. Leukotriene receptor antagonists versus inhaled steroids in asthma.
    Richardson CR
    J Fam Pract; 1999 Jul; 48(7):495-6. PubMed ID: 10428241
    [No Abstract]   [Full Text] [Related]  

  • 22. Intermittent or daily montelukast versus placebo for episodic asthma in children.
    Valovirta E; Boza ML; Robertson CF; Verbruggen N; Smugar SS; Nelsen LM; Knorr BA; Reiss TF; Philip G; Gurner DM
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):518-26. PubMed ID: 21624752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
    Wilson AM; Orr LC; Sims EJ; Dempsey OJ; Lipworth BJ
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1297-301. PubMed ID: 11029334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Montelukast for persistent asthma.
    Med Lett Drugs Ther; 1998 Jul; 40(1031):71-3. PubMed ID: 9698701
    [No Abstract]   [Full Text] [Related]  

  • 25. [Leukotriene antagonist added in asthma therapy. Loophole in anti-inflammatory therapy closed].
    MMW Fortschr Med; 2003 May; 145(18):56. PubMed ID: 12808826
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
    Zsigmond G; Novák Z; Kósa L
    Orv Hetil; 2004 Nov; 145(48):2431-5. PubMed ID: 15638037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in recommended treatments for mild and moderate asthma.
    Redding GJ; Stoloff SW
    J Fam Pract; 2004 Sep; 53(9):692-700. PubMed ID: 15353157
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
    van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
    Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Montelukast and Churg-Strauss syndrome.
    Hosker HS; Tuggey JM
    Thorax; 2001 Mar; 56(3):244. PubMed ID: 11245146
    [No Abstract]   [Full Text] [Related]  

  • 31. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leukotriene receptor antagonist effective in chronic asthma].
    Jébrak G
    Presse Med; 1998 Nov; 27(35):1795. PubMed ID: 9850698
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful outcome of montelukast overdosage in an asthmatic child.
    Geller M; Melo LR; Coutinho SV
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):370. PubMed ID: 10752926
    [No Abstract]   [Full Text] [Related]  

  • 34. Budesonide/formoterol (Symbicort) for asthma.
    Med Lett Drugs Ther; 2008 Feb; 50(1279):9-11. PubMed ID: 18264031
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers.
    Wise RA; Bartlett SJ; Brown ED; Castro M; Cohen R; Holbrook JT; Irvin CG; Rand CS; Sockrider MM; Sugar EA;
    J Allergy Clin Immunol; 2009 Sep; 124(3):436-44, 444e1-8. PubMed ID: 19632710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events associated with weight-based, high-dose montelukast exposures in children.
    Arnold DH; Bowman N; Reiss TF; Hartert TV; Akers WS; Seger DL
    Clin Toxicol (Phila); 2020 Feb; 58(2):145-146. PubMed ID: 31056949
    [No Abstract]   [Full Text] [Related]  

  • 37. Childhood asthma. Balancing efficacy and adherence for optimum management.
    Sveum RJ
    Postgrad Med; 2005 Sep; 118(3):43-50. PubMed ID: 16201308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.
    Knorr B; Nguyen HH; Kearns GL; Villaran C; Boza ML; Reiss TF; Rogers JD; Zhang J; Larson P; Spielberg S
    J Clin Pharmacol; 2001 Jun; 41(6):612-9. PubMed ID: 11402629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reports of suicidality in clinical trials of montelukast.
    Philip G; Hustad C; Noonan G; Malice MP; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):691-6.e6. PubMed ID: 19815114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
    Bacharier LB; Phillips BR; Zeiger RS; Szefler SJ; Martinez FD; Lemanske RF; Sorkness CA; Bloomberg GR; Morgan WJ; Paul IM; Guilbert T; Krawiec M; Covar R; Larsen G; Mellon M; Moss MH; Chinchilli VM; Taussig LM; Strunk RC;
    J Allergy Clin Immunol; 2008 Dec; 122(6):1127-1135.e8. PubMed ID: 18973936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.